Medical Devices

Diabetes Management Continuous Glucose Monitoring Cardiology Patient Safety Product Safety Regulatory Compliance Cardiovascular Devices Manufacturing Surgical Equipment Wearable Technology

Boston Scientific Invests $1.5 Billion for 34% of MiRus, Paving a TAVR Return

The staged deal ties any takeover to clinical results and regulatory clearance to limit risk.

Cormedix Lifts 2026 Outlook After Q1 Beat, Sets H2 FDA Filing Plan for Rizzeo

SANUWAVE Reports Record Q1 Revenue, Sharp Loss Improvement, Sets Full-Year Outlook

Insulet Lifts 2026 Sales Outlook After Strong Q1 on Omnipod 5 Momentum

LivaNova Reports 11% Q1 Growth as FDA PMA and New Data Propel Sleep Apnea Push

Insulet Beats Q1 Targets and Raises 2026 Outlook on Surging Omnipod Sales

Tactile Systems Raises 2026 Outlook on Strong Q1, Lymphotek Integration

Inspire Medical Cuts 2026 Outlook as Coding Snags and Medicare AI Pilot Slow Procedures

iRhythm Lifts 2026 Outlook After Strong Q1 Growth and Margin Gains

Analysts Trim Targets, Still Back Boston Scientific

Survey Finds One in Four Health Systems Hit by Medical Device Cyberattacks

Medtronic Confirms Corporate IT Breach With No Impact on Devices or Care

FDA Clears First Automated Insulin System for Type 1 Diabetes in Pregnancy

Edwards Lifesciences Lifts Outlook After Q1 Beat on Valve Demand

Boston Scientific Meets Q1 Targets and Cuts 2026 Outlook

Intuitive Surgical Posts Q1 Beat and Lifts Procedure Forecast

Beta Bionics Lifts 2026 Sales Outlook as Q1 Revenue Jumps 57%

Abbott Trims 2026 EPS Outlook After Q1 Revenue Beat as Shares Slide

Johnson & Johnson Tops Q1 Forecasts and Lifts 2026 Outlook

PhRMA Chief Steve Ubl to Step Down at Year’s End